[Asia Economy Reporter Ji Yeon-jin] Cellumed announced on the 17th that it has decided to issue convertible bonds worth 10 billion KRW.


The funds raised from the issuance of convertible bonds will be used for acquiring other corporations (8 billion KRW) and facility funds (2 billion KRW). The issuance target is High Value Life Science No.1 Investment Association.


The conversion price is 6,950 KRW, and the number of shares to be issued upon conversion is 1.43 million shares, accounting for 3.64% of the total shares.



On the same day, Cellumed also announced that it will issue convertible bonds worth 5 billion KRW to BNS Investment Advisory. These funds will be used for operating funds of 3 billion KRW and facility funds of 2 billion KRW.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing